ICD-10 Code C50.919: Malignant Neoplasm of Unspecified Site of Unspecified Female Breast
ICD-10-CM code C50.919 is used to document a malignant neoplasm of the female breast when neither the exact tumor site nor laterality (left or right) is specified in the medical record. While this code is valid and billable, it is intended for use only when clinical documentation lacks sufficient anatomical detail.
This guide explains what C50.919 means, when it should be used, associated symptoms, related ICD-10 codes, best-practice coding guidelines, common pitfalls, and trusted resources for accurate reporting.
Related: ICD-10 Code C50.912: Malignant Neoplasm of Unspecified Site of Left Female Breast
What Is ICD-10 Code C50.919?
C50.919 represents breast cancer of an unspecified site and unspecified laterality in a female patient. It belongs to the ICD-10-CM category C50 (Malignant neoplasms of breast) and is used when:
- A malignant breast tumor is confirmed, and
- The documentation does not specify:
- The side of the breast (left or right), or
- The anatomical location within the breast (quadrant or region)
This code supports standardized documentation and reimbursement when detailed clinical information is unavailable at the time of coding.
Detailed Description of C50.919
A malignant neoplasm refers to a cancerous tumor with the potential to invade surrounding tissue or metastasize. In the case of C50.919, the diagnosis confirms breast cancer in a female patient, but the medical record lacks details regarding:
- Tumor laterality (left vs. right breast)
- Tumor location (e.g., upper-outer quadrant, central portion, overlapping sites)
Because ICD-10-CM prioritizes specificity, C50.919 should only be used when no additional details are documented. When laterality or site becomes known, coders should update the diagnosis using a more precise C50.x code.
Common Symptoms Associated With Breast Cancer
Symptoms of malignant neoplasm of the breast—regardless of site or laterality—may include:
- A palpable lump or mass in the breast
- Changes in breast size, shape, or contour
- Nipple discharge, including bloody discharge
- Skin changes such as dimpling, puckering, or redness
- Breast or nipple pain
- Swelling in part or all of the breast
- Enlarged lymph nodes under the arm or near the collarbone
⚠️ Clinical reminder: These symptoms are not diagnostic on their own. Confirmation via mammography, ultrasound, MRI, or biopsy is required before assigning ICD-10 code C50.919.
Related and More Specific ICD-10 Codes
When documentation allows for greater specificity, one of the following codes may be more appropriate:
| ICD-10 Code | Description |
|---|---|
| C50.011 | Malignant neoplasm of nipple and areola, right female breast |
| C50.111 | Malignant neoplasm of central portion, right female breast |
| C50.211 | Malignant neoplasm of upper-inner quadrant, right female breast |
| C50.311 | Malignant neoplasm of lower-inner quadrant, right female breast |
| C50.411 | Malignant neoplasm of upper-outer quadrant, right female breast |
| C50.511 | Malignant neoplasm of lower-outer quadrant, right female breast |
| C50.611 | Malignant neoplasm of axillary tail, right female breast |
| C50.811 | Malignant neoplasm of overlapping sites, right female breast |
👉 Best practice: Always code to the highest level of specificity supported by provider documentation.
ICD-10 Coding Guidelines for C50.919
Use ICD-10 code C50.919 only when all of the following criteria are met:
1. Confirmed Malignancy
- The provider documents a confirmed malignant neoplasm of the breast.
2. Site and Laterality Are Truly Unspecified
- The medical record does not identify:
- The quadrant or anatomical site, or
- Whether the cancer is in the left or right breast
3. Female Patient Only
- C50.919 applies to female patients.
- Male breast cancer requires different ICD-10 codes.
4. Assign Additional Codes When Needed
- Use Z17.– codes for estrogen, progesterone, or HER2 receptor status when documented.
- Code lymph node involvement or metastatic disease separately.
- For transgender patients, follow payer-specific and institutional coding guidance.
Common Coding Errors to Avoid
Avoid these frequent mistakes when using C50.919:
- Using C50.919 when laterality or tumor site is documented elsewhere
- Failing to update the code when more specific information becomes available
- Using the code for benign breast conditions
- Applying C50.919 to male patients
- Confusing breast cancer with skin malignancies of the breast
Accurate code selection reduces claim denials, audit risk, and data quality issues.
Key Resources for Accurate C50.919 Coding
To maintain compliance and accuracy, consult the following authoritative resources:
- ICD-10-CM Official Guidelines for Coding and Reporting
- American Health Information Management Association (AHIMA)
- American Academy of Professional Coders (AAPC)
- American Medical Association (AMA)
- National Comprehensive Cancer Network (NCCN)
These resources support accurate cancer reporting, reimbursement, and clinical documentation.
Frequently Asked Questions
What does ICD-10 code C50.919 represent?
It represents a malignant neoplasm of an unspecified site and unspecified laterality of the female breast.
When should C50.919 be used?
Use C50.919 when breast cancer is confirmed, but neither the tumor location nor the affected breast is documented.
Is C50.919 a billable ICD-10 code?
Yes. C50.919 is a valid, billable diagnosis code for claims submission.
Can C50.919 be used if the breast side is known?
No. If laterality is documented, use a left- or right-specific C50.x code.
Should hormone receptor status be coded separately?
Yes. Assign Z17.– codes when estrogen, progesterone, or HER2 receptor status is documented.
Conclusion:
ICD-10-CM code C50.919 provides a standardized way to document breast cancer in female patients when both site and laterality are unspecified. While appropriate in limited situations, it should be used cautiously and replaced with more specific codes whenever documentation allows.
Accurate use of C50.919 supports:
- Clear clinical communication
- Reliable cancer data reporting
- Accurate billing and reimbursement
- Reduced compliance and audit risk
Looking to improve oncology coding accuracy or reduce unspecified code usage? Review provider documentation practices, follow ICD-10 guidelines closely, and consult certified coding professionals to ensure compliant, high-quality reporting.
